1. MARKETS
  2. SECTOR : HEALTHCARE
  3. INDUSTRY : HEALTHCARE FACILITIES
  4. APOLLO HOSPITALS ENTERPRISE LTD.
Apollo Hospitals Enterprise Ltd.
NSE: APOLLOHOSP | BSE: 508869

Apollo Hospitals Live Share Price Today, Share Analysis and Chart

Mid-range Performer
BasketIn 9 Starfolio Baskets
aboutApollo Hospitals Enterprise Limited (AHEL) is an integrated healthcare provider with a significant presence across the healthcare ecosystem, including hospitals, pharmacies, and primary care clinics. As a leading player in the Indian private healthca... Read More
Ask AI about Apollo Hospitals
8448.00248.00(3.02%)

26.16% Gain from 52W Low

391.4K
NSE+BSE Volume

NSE 30 Oct, 2026 3:31 PM (IST)

Portfolio

Alert

My Notes

Board Meeting
The next board meeting for Apollo Hospitals is on 04 Nov 2026 for the purpose of Quarterly Results and Other business matters See details
Loading...
- / 100
- / 100
54.5 / 100
Mid-range PerformerThese stocks have strong quality. Their reasonable financials and technicals make them potentially attractive to investorsView SimilarEmbed DVM
Analyst Price Target
-

33

S

7

W

7

O

1

T

SWOT Analysis

Check Before You Buy

VIEW FULL CHECKLIST

High rank

17Positive6Negative

Pass in checklist73.9%

045
55
100

PE Valuation Check

Right Now
Undervalued
37.5%
1 Year Forward
Undervalued
62.2%
INSIGHTApollo Hospitals is undervalued at both current PE and future earnings estimates.

Apollo Hospitals Stock Price Analysis

Day Price Range

3.0% 1 Day return
8448 (LTP)
8,1768,448
LowHigh

Week Price Range

9.3% 1 Week return
8448 (LTP)
7,6348,448
LowHigh

Month Price Range

3.5% 1 Month return
8448 (LTP)
7,4658,448
LowHigh

52 Week Price Range

10.0% 1 Year return
8448 (LTP)
6,696.59,070.5
LowHigh
View full Price History/Seasonality

Apollo Hospitals Forecaster - Analyst Share Price Target and Estimates

Revenue forecast

Hit

Apollo Hospitals's Revenue was higher than average estimate 2 times in past 3 years

EPS forecast

CURRENT EPS
134.9
AVG. ESTIMATE
173
LOW ESTIMATE
161.2
HIGH ESTIMATE
181.9
CURRENT EPS
AVG. ESTIMATE
Hit

EPS is expected to grow by 28.2% in FY27

Consensus Recommendation

30 ANALYST Recommendations
STRONG BUY

The consensus recommendation from 30 analysts for Apollo Hospitals is STRONG BUY

Forecaster is a Premium Feature
You need to upgrade your subscription plan to access this feature
See what you get
Upgrade Now

Apollo Hospitals Technical Analysis

Apollo Hospitals EMA & SMA

Bullish+8
8 bullish, 0 bearish
Bullish8
Bearish0
5 Day8145.0
10 Day8021.0
12 Day8010.1
20 Day8050.7
26 Day8108.4
50 Day8289.1
100 Day8351.3
200 Day8162.1

Apollo Hospitals Delivery And Volume

Daily Avg. Delivery Volume %
30 Oct, 202658.5%
Week57.2%
Month60.0%

Apollo Hospitals Active Candlesticks

Marubozu Uptrend Belt Hold Uptrend Closing Marubozu Uptrend Long Line Uptrend
Legend
Positive IndicatorNeutral IndicatorNegative Indicator

Apollo Hospitals Resistance and Support

8357.33
Pivot
First Resistance8538.7
Second Resistance8629.3
Third Resistance8810.7
First Support8266.7
Second Support8085.3
Third Support7994.7
Day RSI59.6
Day MACD-98.3
Day MFI49.7
Day MACD Signal Line-193.9

Apollo Hospitals Beta

1 Month1.3
1 Year0.6
3 Month0.9
3 Year0.6

Apollo Hospitals Price Change Analysis

↑3.5%
Over 1 Month
LowHigh
74658448
↓-5.7%
Over 3 Months
LowHigh
74659070.5
↑10.6%
Over 6 Months
LowHigh
74659070.5
↑10.0%
Over 1 Year
LowHigh
6696.59070.5
All Technicals →

Apollo Hospitals Shareholding Pattern/ Ownership

Shareholding Summary

Sep 2026
 
NameCategorySharesShares %
M/S. Pcr Investments LtdPromoter27,223,12418.9 %
Government Pension Fund GlobalFii2,215,5421.5 %
Sbi Nifty 50 EtfDii3,369,5952.3 %

HISTORICAL PROMOTER HOLDING

HISTORICAL FII HOLDING

HISTORICAL MF HOLDING

All Shareholding details

Apollo Hospitals Deals - Insider, Bulk, Block and SAST

Client NameDeal TypeActionDateAvg. PriceQuantityExchange
BOFA SECURITIES EUROPE SABlockSell19 Nov 2025731259,584NSE
KADENSA MASTER FUNDBlockPurchase19 Nov 2025731259,584NSE
GOLDMAN SACHS BANK EUROPESE-ODIBlockSell10 Nov 2025747492,363NSE
BOFA SECURITIES EUROPE SABlockPurchase10 Nov 2025747492,363NSE
GOLDMAN SACHS (SINGAPORE) PTE - ODIBlockSell17 Sep 20257852.5052,098NSE
GOLDMAN SACHS BANK EUROPE SE - ODIBlockPurchase17 Sep 20257852.5052,098NSE
GOLDMAN SACHS (SINGAPORE) PTE - ODIBlockSell15 Sep 20257874.5040,265NSE
GOLDMAN SACHS BANK EUROPE SE - ODIBlockPurchase15 Sep 20257874.5040,265NSE
GOLDMAN SACHS (SINGAPORE) PTE - ODIBlockSell09 Sep 20257786.5043,031NSE
GOLDMAN SACHS BANK EUROPE SE - ODIBlockPurchase09 Sep 20257786.5043,031NSE
All deals
All insider trades

Apollo Hospitals Corporate Actions

Apollo Hospitals Dividend history and yield

Apollo Hospitals dividend yields, including actual and adjusted, and dividend history, including announcement, record, and ex-dividend dates. Track Apollo Hospitals dividend yield over time.

#Ex-Date
Dividend AmountDividend TypeRecord DateInstrument Type
114 Aug 2026
10FINAL14 Aug 2026Equity Share
216 Feb 2026
10INTERIM16 Feb 2026Equity Share
319 Aug 2025
10FINAL19 Aug 2025Equity Share
414 Feb 2025
9INTERIM15 Feb 2025Equity Share
516 Aug 2024
10FINAL17 Aug 2024Equity Share

Apollo Hospitals Board Meetings

Apollo Hospitals past and upcoming board meetings.

#Ex-Date
PurposeNotes
104 Nov 2026
Quarterly Results and Other business mattersTo approve financial results for the period ended September 30, 2026 and other business matters.
212 Aug 2026
Quarterly Results-
320 May 2026
Audited Results & Final Dividend-
410 Feb 2026
Quarterly Results, Int. Dividend & OthersTo consider other business matters.
506 Nov 2025
Quarterly Results-

Apollo Hospitals Stock Split

Apollo Hospitals stock split details, including announcement, record, and ex-split dates, along with the split ratios

#Ex-Date
Old FVNew FVRecord Date
102 Sep 2010
10503 Sep 2010

Apollo Hospitals Rights issue

Apollo Hospitals rights issue history, along with record, ex-rights dates, and rights ratios.

#Ex-Date
RatioFace ValuePremiumRecord Date
110 Mar 1993
1.0:1.0-1009 Apr 1993
All Corporate Actions

Apollo Hospitals Research Reports

Apollo Hospitals research reports with share price targets, and buy/hold/sell recommendations from top brokers.

#
Date
Broker NameTargetPrice When RecommendedTypeUpsideChange Since RecommendationLinks
113 Aug 2026ICICI Securities Limited
Target
85008920.5Hold-4.71%-5.3%pdf
212 Aug 2026Motilal Oswal
Target
101608600Buy18.14%-1.77%pdf
322 Jun 2026Geojit BNP Paribas
Target
95878487.5Buy12.95%-0.47%pdf
421 May 2026ICICI Direct
Target
96608362.5Buy15.52%1.02%pdf
521 May 2026Prabhudas Lilladhar
Target
93508362.5Buy11.81%1.02%pdf
All Reports of Apollo

Apollo Hospitals Corporate Filings

Apollo Hospitals BSE corporate filings and AGM, press releases, insider trading & SAST, results and corporate actions.

DateAnnouncement TitleDetailsLinks
16 Oct 2026
Apollo Hospitals Enterprise Ltd - 508869 - Intimation Of Schedule Of Analyst/ Institutional Investors Meeting
As per annexure enclosed
PDF
15 Oct 2026
Apollo Hospitals Enterprise Ltd - 508869 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
As per annexure enclosed
PDF
12 Oct 2026
Apollo Hospitals Enterprise Ltd - 508869 - Board Meeting Intimation for Notice Of The Board Meeting
Apollo Hospitals Enterprise Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/11/2026 ,inter alia, to consider and approve As per annexure enclosed
PDF
07 Oct 2026
Apollo Hospitals Enterprise Ltd - 508869 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Regulation 74(5) for the period ended 30th September 2026 is enclosed
PDF
25 Sep 2026
Apollo Hospitals Enterprise Ltd - 508869 - Closure of Trading Window
As per annexure enclosed
PDF
VIEW ALL

Apollo Hospitals DocumentsAsk MarketMind AI

Apollo Hospitals Earnings Call

Apollo Hospitals earnings calls, including management commentary and AI-generated summaries.

DateTitleLinks
13 Aug 2026Apollo Hospitals Enterprise Results Earnings Call for Q1FY27AudioVideo
21 May 2026Apollo Hospitals Enterprise Results Earnings Call for Q4FY26 & Full YearAudioVideo
11 Feb 2026Apollo Hospitals Enterprise Results Earnings Call for Q3FY26AudioVideo
07 Nov 2025Apollo Hospitals Enterprise Results Earnings Call for Q2FY26AudioVideo
13 Aug 2025Apollo Hospitals Enterprise Results Earnings Call for Q1FY26AudioVideo
view all

Apollo Hospitals Annual Reports

Apollo Hospitals financials, including annual results, balance sheets, and cash flow statements.

DateReport TitleLinks
2026Annual Report Mar-2026Link
2025Annual Report Mar-2025Link
2024Annual Report Mar-2024Link
2023Annual Report Mar-2023Link
2022Annual Report Mar-2022Link

Apollo Hospitals Credit Ratings

Apollo Hospitals credit ratings from CRISIL and leading rating agencies, assessing financial stability, investment grade, and related PDF documentation.

DateRating AgencyCompany NameDescriptionLinks
20 Aug 2026crisil ratingsApollo Hospitals North LimitedApollo Hospitals North Limited:Long-term rating continues on 'Watch Positive'; Short-term rating reaffirmedLink
18 Jun 2026icra ratingsApollo Hospitals Enterprise LimitedChange in LimitsLink
28 May 2026crisil ratingsApollo Hospitals North LimitedApollo Hospitals North Limited:Long-term rating placed on 'Watch Positive'; 'Crisil A1+' assigned to short-term bank debt; Rated amount enhanced for Bank DebtLink
28 May 2026crisil ratingsApollo Hospitals Enterprise LimitedApollo Hospitals Enterprise Limited:Update on Apollo Hospitals Enterprise LimitedLink
17 May 2026icra ratingsApollo Hospitals Enterprise Limited[ICRA]AAA (Stable)/[ICRA]A1+; assignedLink

Apollo Hospitals Investor Presentations

Apollo Hospitals investor presentations, including business updates, financial insights, and strategic initiatives.

DateReport TitleLinks
12 Aug 2026Apollo Hospitals Enterprise Ltd - 508869 - Announcement under Regulation 30 (LODR)-Investor PresentationLink
20 May 2026Apollo Hospitals Enterprise Ltd - 508869 - Announcement under Regulation 30 (LODR)-Investor PresentationLink
10 Feb 2026Apollo Hospitals Enterprise Ltd - 508869 - Announcement under Regulation 30 (LODR)-Investor PresentationLink
06 Nov 2025Apollo Hospitals Enterprise Ltd - 508869 - Announcement under Regulation 30 (LODR)-Investor PresentationLink
30 Jun 2025Apollo Hospitals Enterprise Ltd - 508869 - Announcement under Regulation 30 (LODR)-Investor PresentationLink

Apollo Hospitals - Company Profile

Apollo Hospitals Management Structure

Apollo Hospitals management structure with salaries, total experience, and qualifications.

NAMEDESIGNATIONGROSS REMUNERATION ₹(LAC)AS OFHISTORY & DETAILS
Dr. Madhu SasidharPresident,Chief Executive Officer(Hospitals Division)-Mar 26
Shri. Krishnan AkhileswaranChief Financial Officer-Mar 26
S M KRISHNANCompany Secretary,Compliance Officer,Senior Vice President(Finance)-Mar 26
Dr. Anupam SibalMedical Director-Mar 26
Capt Dr Usha BanerjeeSenior Nursing Officer-Mar 26
Shri Ashok SomuveerappanChief Information Officer-Mar 26
Shri Mayank RautelaChief Human Resources Officer(Human Resources)-Mar 26

Apollo Hospitals Board of Directors

Apollo Hospitals Board of directors with salaries, total experience, and qualifications.

NAMEPOSITIONGROSS REMUNERATION ₹(LAC)AS OFHISTORY & DETAILS
Prathap C ReddyChairman & Exec. Director2025Mar 26
Suneeta ReddyED / MD / Promoter953.4Mar 26
Preetha ReddyVice Chairperson941.7Mar 26
Sangita ReddyED / Joint MD / Promoter939.6Mar 26
SHOBANA KAMINENINon-Exec & Non-Independent Dir806.4Mar 26
M B N RaoIndependent Non Exe. Director60Mar 26
Kavitha D ChitturiIndependent Non Exe. Director58Mar 26
Murali DoraiswamyIndependent Non Exe. Director57Mar 26
Som MittalIndependent Non Exe. Director57Mar 26
Rama BijapurkarIndependent Non Exe. Director50Mar 26
S M KRISHNANSVP / Company Secretary / Compliance Officer-Mar 26

Apollo Hospitals Brands

Brands owned by Apollo Hospitals

LOGOBRAND NAME
Apollo Hospitals Enterprise
Website: www.apollohospitals.com

About the company - Business Profile

Apollo Hospitals Enterprise Limited (AHEL) is an integrated healthcare provider with a significant presence across the healthcare ecosystem, including hospitals, pharmacies, and primary care clinics. As a leading player in the Indian private healthcare sector, the company operates a network of owned and managed hospitals, providing tertiary and quaternary care. Its business model integrates physical hospitals with digital health services through the Apollo 24/7 platform and an extensive retail pharmacy network, positioning it as a comprehensive health services provider in India and select international markets.

Key Points

  • Key Facts: Founded in 1979 and headquartered in Chennai, India, Apollo Hospitals is listed on the BSE and NSE. It is the flagship entity of the Apollo Hospitals Group.
  • Operations and Resources: As of September 2025, the company operates 73 hospitals with a total capacity of 10,100+ beds. Its retail footprint includes 6,030 pharmacy outlets, 2,366 diagnostic centers, and 352 clinics. Notable assets include the Apollo Proton Cancer Centre in Chennai, the first of its kind in Southeast Asia.
  • Ownership: The company is promoter-led, with the Reddy family holding a significant stake. It transitioned from a single hospital in Chennai to a pan-India network through organic growth and strategic acquisitions.
  • Market and Significance: Apollo serves 24 states and 4 Union Territories in India and has a presence in 4 international locations including Bahrain and Bangladesh. It serves key specialties such as Cardiology (19% of inpatient revenue), Oncology (8%), and Neurosciences (9%).
  • Business Model: The company operates through three primary segments:
    1. Healthcare Services: Multi-specialty hospitals and pharmacies within hospitals.
    2. Apollo HealthCo: Combines the digital platform (Apollo 24/7) with the pharmacy distribution and retail network.
    3. Apollo Health and Lifestyle (AHLL): Retail healthcare including clinics, diagnostics, and specialty centers (cradles, surgery centers).
  • Financial Performance (FY25 Annual):
    • Revenue from Operations: Increased by 13% for Hospitals, 14% for AHLL, and 16% for HealthCo compared to the previous year.
    • Pharmacy Distribution: Recorded a 16% growth driven by a network of 6,626 retail stores.
    • Healthcare Services Metrics: Average Revenue Per Inpatient (ARPI) stood at ₹162,902, a 7% increase. Inpatient discharges reached 604,250.
  • Revenue Breakdown (Q3FY26):
    • Healthcare Services: ₹31,832 million (14% YoY growth).
    • Apollo HealthCo (Offline Pharmacy & Online 24/7): ₹28,274 million (20% YoY growth).
    • AHLL (Diagnostics & Retail): ₹4,668 million (20% YoY growth).
  • Key Products and Technology:
    • Apollo 24/7: A digital healthcare platform for consultations, medicine delivery, and lab tests.
    • Clinical Excellence: The company utilizes AI-based tools for clinical decision support and manages one of the largest specialized proton therapy centers for cancer treatment.
  • Strategic Initiatives and Future Outlook:
    • Expansion: Planning to add 4,400 capacity beds (~3,600 census beds) over the next five years with an estimated project cost of ₹8,294 crore.
    • Major upcoming projects include new facilities in Worli (Mumbai), OMR (Chennai), and Varanasi, along with brownfield expansions in Hyderabad and Lucknow.
    • The company aims to reach a total of ~13,100 beds post-expansion.

References

  1. Investor Presentation Feb 2026
  2. Investor Presentation Nov 2025
  3. Annual Report May 2025
  4. Annual Report May 2024

Apollo Hospitals FAQ

Apollo Hospitals today is trading in the green, up by 3.02% at ₹8,448.
Apollo Hospitals is currently trading up 3.02% on an intraday basis. In the past week the stock rose 9.29%. Stock has been down 5.68% in the past quarter and rose 9.99% in the past year. You can view this in the share price history/seasonality section.
Apollo Hospitals is listed on NSE with the ticker APOLLOHOSP and on BSE as 508869. It's currently trading on NSE at a share price of ₹8,448 and on BSE with a share price of ₹8,400.
The market cap of Apollo Hospitals is ₹121,469.31 Cr. as of Oct 30, 2026.
Apollo Hospitals announced a FINAL dividend of 200% which equals ₹10 in Aug 14, 2026.The last three ex-dates for Apollo Hospitals were Feb 16, 2026, Aug 19, 2025 and Feb 14, 2025. To view the full dividend history of Apollo Hospitals click here.
Apollo Hospitals has never issued bonus shares, but it has issued 1 stock split since its BSE/NSE listing. The latest announcement for Apollo Hospitals stock split was on Sep 02, 2010 at a ratio of 10:5.
Apollo Hospitals reported ₹7,092.3 Cr. in revenue, ₹580.7 Cr. in net profit, and ₹1,140.9 Cr. in EBITD as of Aug 12, 2026 for Q1 FY26-27.
According to the predictions of 30 analysts, the share price prediction for Apollo Hospitals is ₹9,802.33 with an upside of 16%.
The PE ratio of Apollo Hospitals is 58.13 as of Oct 30, 2026.
The PB ratio of Apollo Hospitals is 12.05 as of Oct 30, 2026.
You can view the latest analyst reports on the Apollo Hospitals reports dashboard. Either click on the Reports tab on this page's sub-header or click here to be directed to the dashboard.
You can set real-time stock alerts on price, volume, SMA, and several other parameters by scrolling to the top of this page and clicking the bell icon on the far right-hand side of the stock overview.
Ask AI
×